MedPath

Impatto Emodinamico Dell'Anestesia Subaracnoidea Titrata Versus Tecnica Single-shot Nei Pazienti Sottoposti ad Artroprotesi d'Anca. RCT

Not Applicable
Completed
Conditions
Anesthesia; Adverse Effect
Anesthesia, Local
Interventions
Procedure: subarachnoid block
Registration Number
NCT05868642
Lead Sponsor
Istituto Ortopedico Rizzoli
Brief Summary

Studying the hemodynamic effects of titrated subarachnoid anesthesia versus conventional single-shot subarachnoid anesthesia

Detailed Description

This study aims to investigate whether a different hemodynamic effect is related to the injection o titrated local anesthetic for subarachnoid anesthesia versus the conventional single shot injection. The data to be recorded are blood pressure and pulse rate at different timing. As secondary outcomes the investigators will record the anesthetic level achieved using the Bromage score.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
82
Inclusion Criteria
  • BMI 20-40 kg/m2
  • ASA 1-3
  • undergoing total hip arthroplasty
  • no controindications to subaracnhoid block
  • able to understand and sign a written informed consensus
  • METs > o = 4
Exclusion Criteria
  • baseline SBP < 100 mmHg

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
T groupsubarachnoid blockSubaracnhoid block levobupivacaine 0.5%, 10 mg (2 ml) via subarachnoid injection plus 1mg for each metameric level needed to achieve the T10 level sensory block (evaluation with pinprick test at 10 minute after the firts injection and at 4 minute from the second injection)
S groupsubarachnoid blocklevobupivacaine 0.5%, 15 mg (3 ml) via subarachnoid injection
Primary Outcome Measures
NameTimeMethod
SBP change60 minute

SBP will be recorded at baseline and every 5 minutes after the subarachnoid block for 1 hour

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Istituto Ortopedico Rizzoli

🇮🇹

Bologna, BO, Italy

© Copyright 2025. All Rights Reserved by MedPath